Jul 18, 2025
364:361
For every 361 shares held, investors received 364. The price per share adjusted from $53.50 to $53.06.
The split itself did not change the total investment value.
Tanvex Biopharma, Inc. (TWSE:6541) operates in the Pharmaceuticals: major industry.
Tanvex Biopharma, Inc. company overviewTanvex Biopharma, Inc.'s most recent stock split was on July 18, 2025. It was a 364-for-361 forward split, so shareholders received 364 shares for every 361 they held.
Tanvex Biopharma, Inc. (TWSE:6541) has split its stock 7 times: a 553-for-548 split on July 10, 2018, a 153-for-152 split on November 4, 2019, a 543-for-532 split on November 25, 2020, a 108-for-107 split on September 7, 2021, a 703-for-689 split on March 27, 2023, a 316-for-313 split on March 21, 2024, and a 364-for-361 split on July 18, 2025.
Tanvex Biopharma, Inc. has split its stock 7 times. This history records 7 forward splits between July 10, 2018 and July 18, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Tanvex Biopharma, Inc.'s 364-for-361 split on July 18, 2025, every 361 shares became 364 shares.
Tanvex Biopharma, Inc. has not announced a new split in our records. Its most recent split was on July 18, 2025, 1 year ago. Companies announce splits in advance, and any new TWSE:6541 split will appear on this page.
Already premium?